16-51137264-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002968.3(SALL1):c.3823G>C(p.Val1275Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1275I) has been classified as Benign.
Frequency
Consequence
NM_002968.3 missense
Scores
Clinical Significance
Conservation
Publications
- Townes-Brocks syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
- Townes-Brocks syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002968.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SALL1 | TSL:1 MANE Select | c.3823G>C | p.Val1275Leu | missense | Exon 3 of 3 | ENSP00000251020.4 | Q9NSC2-1 | ||
| SALL1 | TSL:1 | c.*260G>C | 3_prime_UTR | Exon 2 of 2 | ENSP00000455582.1 | H3BQ32 | |||
| SALL1 | TSL:5 | c.3823G>C | p.Val1275Leu | missense | Exon 4 of 4 | ENSP00000407914.2 | Q9NSC2-1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Cov.: 63
GnomAD4 genome Cov.: 29
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at